Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Menu

Myambutol 100 mg Tablets 1X100 Mfg. By X-Gen Pharmaceuticals Inc

Image 0 of Myambutol 100 mg Tablets 1X100 Mfg. By X-Gen Pharmaceuticals IncImage 1 of Myambutol 100 mg Tablets 1X100 Mfg. By X-Gen Pharmaceuticals IncImage 2 of Myambutol 100 mg Tablets 1X100 Mfg. By X-Gen Pharmaceuticals Inc

Myambutol 100 mg Tablets 1X100 Mfg. By X-Gen Pharmaceuticals Inc

Call for Price

Myambutol 100 mg Tablets 1X100 Mfg. By X-Gen Pharmaceuticals Inc This Item Requires A Valid Order From A Physician Licensed in The USA. Item No.:RXD3620887/RXB10029261 NDC No.:68850-0010-01 Generic Name:Ethambutol Hcl Subcategory Name: Myambutol UPC No.: 368850010014 Mfg.Item No.:010-01

Have a question?

  Call for Price

MYAMBUTOL
(ethambutol hcl) Tablets

DRUG DESCRIPTION

MYAMBUTOL ethambutol hydrochloride is an oral chemotherapeutic agent which is specifically effective against actively growing microorganisms of the genus Mycobacterium, including M. tuberculosis.

MYAMBUTOL 100 and 400 mg tablets contain the following inactive ingredients: Gelatin, Hydroxypropyl Methylcellulose, Magnesium Stearate, Sodium Lauryl Sulfate, Sorbitol, Stearic Acid, Sucrose, Titanium Dioxide and other ingredients.

INDICATIONS

MYAMBUTOL is indicated for the treatment of pulmonary tuberculosis. It should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. Selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in-vitro susceptibility studies. In patients who have not received previous antituberculous therapy, ie, initial treatment, the most frequently used regimens have been the following:

MYAMBUTOL plus isoniazid

MYAMBUTOL plus isoniazid plus streptomycin.

In patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. Consequently, in such retreatment patients, MYAMBUTOL should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in-vitro studies. Antituberculous drugs used with MYAMBUTOL have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. Isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. Alternating drug regimens have also been utilized.